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A gradual restriction in lineage potential of multipo-
tent stem/progenitor cells is a hallmark of adult he-
matopoiesis, but the underlying molecular events
governing these processes remain incompletely
understood. Here, we identified robust expression
of the leukemia-associated transcription factor
hepatic leukemia factor (Hlf) in normal multipotent
hematopoietic progenitors, which was rapidly down-
regulated upon differentiation. Interference with its
normal downregulation revealed Hlf as a strong
negative regulator of lymphoid development, while
remaining compatible with myeloid fates. Recipro-
cally, we observed rapid lymphoid commitment
upon reduced Hlf activity. The arising phenotypes
resulted from Hlf binding to active enhancers of
myeloid-competent cells, transcriptional induction
of myeloid, and ablation of lymphoid gene programs,
with Hlf induction of nuclear factor I C (Nfic) as a
functionally relevant target gene. Thereby, our
studies establish Hlf as a key regulator of the earliest
lineage-commitment events at the transition from
multipotency to lineage-restricted progeny, with
implications for both normal and malignant
hematopoiesis.INTRODUCTION
Blood cell formation is often viewed in a hierarchical manner, in
which hematopoietic stem cells (HSCs) reside at the apex of the
hematopoietic hierarchy (Figure 1A). Upon differentiation, HSCs
produce intermediate progenitors with increasingly restricted
lineage potential (Figure 1A). Although the extensive self-renewal
that characterizes HSCs is lost in the initial stages of HSC differ-
entiation, most existing data suggest that multipotency is re-
tained. Thereafter, progenitors gradually lose multipotencyCell Repor
This is an open access article under the CC BY-Nthrough a branched differentiation scheme. Eventually, progen-
itors become locked to only one lineage, after which lineage-
specific maturation events commence (Bryder et al., 2006;
Mercer et al., 2011).
The lymphoid lineages (B, T and natural killer [NK] cells) branch
from a common lymphoid progenitor (CLP) (Kondo et al., 1997).
The generation of CLPs from upstream multipotent progenitors
involves upregulation of lymphoid specification factors, such as
Tcf3, Gfi-1, and Ikaros (Mercer et al., 2011). CLPs give rise to
committed B cell progenitors, a process guided by a network of
transcription factors (TFs) that includes Foxo1, Ebf1, and Pax5
(Mercer et al., 2011). Following initial maturation in the bone
marrow (BM), immature B cells home to secondary hematopoiet-
ic organs for further maturation (Hardy and Hayakawa, 2001).
T cells represent the other major lineage of lymphopoiesis.
Although amatter of dispute, much data support that the earliest
T cell progenitors (ETPs) can be generated from CLPs, although
alternative parental progenitors might also exist (Allman et al.,
2003; Benz et al., 2008; Kondo et al., 1997; Yang et al., 2010).
Regardless, alternative lineage options of ETPs can be over-
ridden by Notch signaling in the thymus, which acts by locking
cells to the T cell lineage (Yang et al., 2010). In the thymus,
ETPs mature through a series of immature progenitor stages
(DN1–DN4) to eventually give rise to more mature T cells that
are exported from the thymus (Germain, 2002). Myelopoiesis
(giving rise to granulocytes, macrophages, erythroid cells, and
platelets) represents the other dominant branch of hematopoie-
sis. Work from others and us has provided insight into the first
stages of specification for these lineages (Akashi et al., 2000;
Pronk et al., 2007). For instance, granulocyte/monocyte/
lymphoid progenitors (GMLPs) retain a combined lymphoid and
granulocyte/monocyte potential but harbor little or no erythroid
(E) or megakaryocytic (Meg) potential (Adolfsson et al., 2005;
Arinobu et al., 2007). Instead, the Meg and erythroid lineages
are generated from a common pre-MegE progenitor, whose
closest upstream progenitors remain a matter of debate (Adolfs-
son et al., 2005; Arinobu et al., 2007; Forsberg et al., 2006; Pronk
et al., 2007; Sanjuan-Pla et al., 2013; Yamamoto et al., 2013).
Previously, we established the genome-wide expression
patterns of highly purified HSCs and a range of definedts 21, 2251–2263, November 21, 2017 ª 2017 The Author(s). 2251
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Identification of Hlf as a Candidate Regulator of Early Hematopoiesis
(A) Schematic depiction of the progenitor subsets that underlie the early stages of hematopoiesis.
(B) Heatmap showing the expression levels of TFs displaying 2-fold or higher expression in HSCs and GMLPs compared with downstream progenitor cell
types (mean values of three replicate arrays per cell type, except for HSCs and pMegEs, for which six and five replicate arrays were used, respectively). See also
Table S1.
(C) Schematic depiction of the different lentiviral constructs used for OP9 stromal co-cultures.
(D) The lineage output relative to controls of B cells, NK cells, and myeloid cells produced from Hlf/Hlf, Hlf/Dbp, Hlf/Tef, Hlf/Nfil3, Hlf, Nfil3, and M33-Hlf
transduced GMLPs in OP9 stroma co-cultures (n = 6, 6, 6, 6, 6, 3, 6, and 45 cultures, respectively, from two independent experiments).
(E) B, NK, and myeloid cell generation in OP9 co-culture experiments and T cell generation in OP9-DL1 co-cultures using Hlf-inducible GMLPs cultured in the
absence or presence of DOX. Shown are representative FACS plots as well as bar graphs showing the frequency relative to untreated controls of CD19+ B cells,
NK1.1+ NK cells, CD11b+myeloid cells, and CD90+ T cells in the cultures from three independent experiments (n = 5 for the B, NK, and myeloid experiments, and
n = 9 for the T cell experiments).
Error bars denote SEM. CFU-erythroid, colony-forming unit-erythroid; MkP, megakaryocyte progenitor; pCFU-erythroid, pre-colony-forming unit-erythroid;
pGM, pre-granulocyte-monocyte progenitor; pMeg/erythroid, pre-megakaryocyte-erythroid progenitor. See also Figures S1 and S2.hematopoietic progenitor subsets (Norddahl et al., 2011; Pronk
et al., 2007, 2008; Wahlestedt et al., 2013; Weishaupt et al.,
2010; Figure 1A). When interrogating these datasets for expres-
sion of TFs that associate with multipotency and rapid down-
regulation with differentiation (Figures 1B, S1, and S2), we2252 Cell Reports 21, 2251–2263, November 21, 2017identified hepatic leukemia factor (Hlf), a TF of the proline and
acidic amino acid-rich basic leucine zipper family, previously
studied for its role in circadian rhythm regulated neurotransmitter
metabolism in the brain (Gachon et al., 2004; Mitsui et al., 2001),
xenobiotic detoxification in the liver (Gachon et al., 2006), and
renal function (Zuber et al., 2009). Although Hlf was originally
proposed to not be expressed in BM (Inukai et al., 2005), later
studies found its promoter differentially methylated in between
multipotent progenitor cells and more committed cells (Ji et al.,
2010), with enforced expression of Hlf linked to enhanced
self-renewal (Gazit et al., 2013; Shojaei et al., 2005). More
recently, Hlf was identified as a necessary factor to revert
committed blood cells back into an HSC-like state (Riddell
et al., 2014). Hlf has perhaps a more well established connection
to leukemia as the fusion partner of TCF3/E2A resulting from
the t(17;19) translocation, a rare but recurrent event associated
with a highly aggressive subset of acute B-lymphoblastic
leukemia (Fischer et al., 2015; Hunger et al., 1992; Inaba et al.,
1992). However, little is known on how Hlf might influence on
normal hematopoietic differentiation. Therefore, we set out to
characterize the role of Hlf in normal hematopoietic lineage
development.
RESULTS
Prolonged Hlf Expression Critically Influences
Multilineage Hematopoietic Differentiation
To begin to dissect the impact of Hlf on hematopoietic develop-
ment, we first generated lentiviral constructs that included a
single-copy Hlf overexpression vector and a construct in which
Hlf is expressed as a forced homodimer (Hlf/Hlf; Figure 1C).
We chose this complementary approach because HLH TFs
generally target DNA as dimers. Although expression data
suggested that Hlf is the only PAR bZIP family member with
selectively high expression in immature blood cells, Hlf may
affect early hematopoiesis by heterodimerizing with any of its
other family members upon differentiation. We therefore also
generated Hlf/Dbp, Hlf/Nfil3, andHlf/Tef forced dimer constructs
(Figure 1C) along with an Nfil3 overexpression vector, the latter
because Nfil3 has been reported to act antagonistically to Hlf
(Mitsui et al., 2001).
After confirmation of relevant Hlf expression induced by the
different viral constructs (Figure S3A), transduced multipotent
GMLPs were assessed using the OP9 stromal cell system
(Nakano et al., 1994). These experiments revealed that Hlf and
Hlf/Hlf overexpressing GMLPs displayed a strikingly reduced
capacity to differentiate into CD19+ B cells and NK1.1+ NK cells,
but with enhanced generation of Gr-1+/CD11b+ myeloid
(Figure 1D). Overexpression of Nfil3 led to almost exclusive
differentiation into NK cells (Figure 1D), reinforcing the impor-
tance of Nfil3 for NK cell development (Kamizono et al., 2009).
A similar increase in NK cell development was observed from
cells transduced with the Hlf/Nfil3 heterodimer construct (Fig-
ure 1D), suggesting that Nfil3 acts dominantly over Hlf. Finally,
Hlf/Dbp and Hlf/Tef presented with an intermediate reduction
in B and NK cell differentiation and an increase in myelopoiesis
(Figure 1D).
To obtain a more controllable transgenic system, we next
established a Tet-ON mouse model that upon doxycycline
(DOX) administration allows conditional expression of Hlf (Fig-
ure S3B). Although systemic administration of DOX in these
mice results in ubiquitous induction of transgene expression,
its combination with cell isolation allows inducible expressionof Hlf in any cell type of choice. To verify this model, we isolated
Hlf-inducible GMLPs and subjected them to the OP9 co-culture
system. In addition, we also investigated T lymphopoiesis by
culturing transgenic GMLPs on OP9-DL1 stromal cells (Schmitt
and Zu´n˜iga-Pfl€ucker, 2002). These experiments confirmed our
previous findings using lentiviral-mediated transgenesis (Fig-
ure 1E), and OP9-DL1 co-culture experiments revealed that a
failure to downregulate Hlf also inhibited T cell development
(Figure 1E).
In Vivo Induction of Hlf Associates with Enhanced
Myelopoiesis and Repressed Lymphopoiesis
To investigate the roles of Hlf in vivo, we provided Hlf-inducible
mice with DOX via their food. Analyses of BM from these mice
revealed a slight but significant reduction in overall cellularity
as early as 3 days following Hlf induction (Figure S4A). To inves-
tigate hematopoiesis in detail, we enumerated multipotent cell
compartments (HSCs and GMLPs), early myeloid precursors,
and different stages of B cell development (Figure S4B and Table
S1). HSC numbers in the BM of Hlf-induced mice were mildly
increased at 3 days and decreased at 14 days of Hlf induction
(Figure 2A). GMLPs were unaltered at all time points except
following 11 days of Hlf induction, when a slight decrease in their
numbers was observed (Figure 2A). By contrast, we observed a
robust and progressive increase of pre-granulocyte-monocyte
progenitors (pGMs) and granulocyte-monocyte progenitors
(GMPs) over time (Figure 2A). Investigations into early lymphoid
development in the BM revealed a slightly decreased abundance
of B cell-biased lymphoid progenitors (BLPs) (Inlay et al., 2009)
(Figure 2A). A more dramatic depletion was observed in down-
stream B lymphocyte precursor populations, including Hardy’s
fractions A, B-C, C0-D, and E (Hardy et al., 1991; Tung et al.,
2004) (Figure 2B). By contrast, fraction F cells (mature recirculat-
ing B cells) (Hardy et al., 1991; Tung et al., 2004) were less
affected (Figure 2B). These observations were accompanied
by marked increases of a BM cell population with a
LinB220+CD19+CD24+IgMIgDc-Kit+IL7Ra+ phenotype (Fig-
ure 2B). Retention of CD19 expression in vitro when cultured
on both OP9 and OP9-DL1 stroma (data not shown), expression
of several B cell-associated genes at levels comparable
with fraction B-C cells, varying degrees of DJ and VDJ heavy-
chain rearrangements, and their cell surface marker profile
strongly suggested that they indeed represented a subset
of early B cell progenitors (Figure S5). When Hlf was induced
in fraction B-C cells for 48 hr, a large fraction of the cells
(31.5 ± 8.1%, as opposed to 10.4 ± 3.6% of control cells) upre-
gulated c-kit expression (Figure S4E), further emphasizing that
the differentiation block in the B cell lineage caused by Hlf
associates with a rapid induction of c-kit expression. In the
spleen, the frequency of immature B cells was progressively
decreased upon Hlf induction, whereas mature follicular B cells
and marginal zone B cells were less affected (Figure 2B). The
negative impact of Hlf on B lymphopoiesis therefore starts early
and affects multiple progenitor stages, with little or no impact on
more mature B cells.
We next asked whether Hlf might affect T cell development
in vivo. Surprisingly, as early as 3 days after initiation of Hlf
expression, we observed pronounced thymic atrophy thatCell Reports 21, 2251–2263, November 21, 2017 2253
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Figure 2. Hlf Induction In Vivo Negatively Influences Lymphopoiesis at the Expense of Enhanced Myelopoiesis
Hlf-inducible mice were given DOX via their food pellets for 0, 3, 7, 11, and 14 days (n = 7, 7, 7, 3, and 4 mice in each group, respectively, from two independent
experiments) and 38 weeks (n = 5 mice, from one experiment).
(A) Bar charts showing the amount of HSCs, GMLPs, pGMs, GMPs, all lymphoid progenitors (ALPs), and B cell-biased lymphoid progenitors (BLPs) in the BM of
the analyzed mice (relative to uninduced mice).
(B) Relative cell numbers of the analyzed B cell subsets in the BM and relative frequencies of the indicated splenic B cell fractions among all splenocytes in
the analyzed mice (relative to uninduced mice). See also Figure S5.
(C) Photographs depicting thymi after 0, 3, 7, 11, and 14 days of enforced Hlf expression (four thymi per time point, representative of one of three experiments).
The scale bar represents 1 cm.
(D) The amount of CD4+CD8+ double-positive, single-positive CD4+, single-positive CD8+ thymocytes, and DN1, DN2, and DN3 thymocytes following the
different number of days of DOX administration (relative to uninduced mice). See also Table S1.
Error bars denote SEM. ALP, all lymphoid progenitor; BM, bone marrow; BLP, B cell biased lymphoid progenitor; DN, double negative. See also Figures S3
and S4.progressed rapidly (Figure 2C). Reasoning that this might be
connected to thymic T cell development, we enumerated
different T cell compartments (Figure S4C). After 3 days, CD4+
and CD8+ single-positive T cells were present at normal
numbers, whereas CD4+CD8+ double-positive T cell numbers
were dramatically decreased (Figure 2D). Analysis of
CD4+CD8+ cells following brief Hlf induction in vitro revealed a
massive induction of apoptosis (Figure S4D). Upon longer Hlf
induction, the decrease in CD4+CD8+ cells persisted and
single-positive subsets gradually decreased in numbers, such
that by day 14, levels were only 5.7% (CD4+) and 10.2%
(CD8+) of those observed in control mice (Figure 2D). When
investigating more primitive T cell fractions, we observed a pro-
nounced decrease in double-negative (DN) 1 cells (Figure 2D)
from day 7 onward. DN2 cells were greatly expanded following
3 days of induction (7-fold; Figure 2D). However, this was
attenuated 4 days later, and at 11 and 14 days, their levels
displayed a decreasing trend compared with control mice (Fig-
ure 2D). Last, DN3 cells were present at normal numbers up to2254 Cell Reports 21, 2251–2263, November 21, 201711 days following Hlf induction but decreased by day 14 and at
later time points (Figure 2D and data not shown).
Hlf Acts Intrinsically on Hematopoiesis
To exclude the possibility that Hlf mediates an indirect effect, we
next transplanted Hlf-inducible GMLPs into sublethally irradiated
wild-type (WT) mice under continuous Hlf induction. Twenty-one
days post-transplantation, theHlf-induced cells presentedwith a
dramatic (28-fold) increase in myeloid cell reconstitution in the
BM (Figure 3A). Somewhat surprisingly, we observed that
CD19+ BM B cell reconstitution was increased 12-fold over the
control (Figure 3A). More detailed examination revealed that
these cells were almost exclusively restricted to the aforemen-
tioned population with a LinB220+CD19+c-Kit+IL7Ra+ pheno-
type (Figure 3B). Despite the dramatic expansion of this subset
in the BM, B cell reconstitution was dramatically reduced in
the spleen (3.4-fold) (Figure 3C) and in peripheral blood (PB)
(5.7-fold) (Figure 3D). In agreement with the increased myeloid
reconstitution in the BM, donor-derived myeloid cell abundance
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Figure 3. Cell-Autonomous Alterations Underlie the Altered Hematopoiesis Following Enforced Hlf Expression In Vivo
Hlf-inducible GMLPs (CD45.1+) were transplanted into sublethally irradiatedWT recipient hosts (CD45.2+) maintained on a DOX food diet (n = 6 and 7mice for the
control and DOX groups, respectively, from one of three experiments with similar results).
(A) Magnitudes of myeloid B, and T cell reconstitution in the BM of the recipient mice.
(B) FACS plots showing the appearance of CD45.1+c-Kit+IL7Ra+CD19+ cells in the BM of mice transplanted with Hlf-induced GMLPs.
(C and D) Donor-derived reconstitution of myeloid, B, and T cells in the spleen (C) and the PB (D).
(E) The thymi of recipient mice were assessed for donor-derived reconstitution of the indicated thymocyte subsets.
Error bars denote SEM. See also Figure S5.was increased 8.3-fold and 10.1-fold in the spleen and PB,
respectively (Figures 3C and 3D). In the thymus, Hlf induction
led to a total absence of donor-derived CD4+, CD8+, or
CD4+CD8+ cells (Figure 3E). Although reconstitution of the
more primitive DN1–DN3 cells was significantly lower than
from control cells, their presence in induced mice suggested
that initial homing to the thymus was at least to some degree
functional (Figure 3E).
Acute Loss and the Modulation of Hlf into a
Transcriptional Repressor Enhance Lymphopoiesis
from Multipotent Progenitors
Next, we approached the roles of Hlf from a loss-of-function
perspective. Because Hlf is rapidly downregulated upon normal
differentiation, traditional knockout experiments provide little
information. Therefore, we first transplanted mice with Hlf trans-
genic GMLPs under Hlf induction for 14 days. This was followed
by removal of Hlf induction for 8 days to reduce Hlf levels.
Compared with cells with continuous Hlf expression, Hlf deple-
tion resulted in a rapid shift in PB lineage distribution, owing to
an 8.7-fold increase in B cells (Figure 4A). Similarly, although
continuous Hlf expression failed to associate with splenic T cell
reconstitution, we detected low but consistent T cell generation
following Hlf withdrawal (Figure 4A). Investigations of the BM re-
vealed that the otherwise vastly expanded LinB220+CD19+c-
Kit+IL7Ra+ population had greatly decreased in size (10.9-fold)
following Hlf depletion, which coincided with strikingly elevated
numbers at all stages of early B lymphopoiesis. Thus, the accu-
mulation of this population represents a differentiation block thatis released following DOX withdrawal (Figure 4A). In this setting,
we failed to observe a decrease in myeloid cell output upon DOX
withdrawal, which likely reflects the limited self-renewal potential
of GMLPs and the fact that myeloid lineage commitment has
already commenced during the induction period.
We next generated an M33-Hlf construct, in which the strong
repressive domain of the polycomb gene M33 (Cbx2) is pre-
dicted to turn Hlf from a transcriptional activator into a repressor
(Argiropoulos et al., 2010). We reasoned that such an approach
was highly relevant, given that Hlf associated mostly with
transcriptionally active genes (see below). We introduced the
M33-Hlf construct into WT GMLPs and subjected cells to OP9
andOP9-DL1 differentiation conditions. In OP9 cultures, expres-
sion of M33-Hlf led to an increased production of B cells and NK
cells, with little influence on myeloid cell generation (Figure 4B).
In OP9-DL1 co-cultures, the overall T cell production from
M33-Hlf expressing GMLPs was enhanced, mainly because of
an increase of DN3 cells at the expense of DN1 and DN2 cells
(Figure 4C).
The Genome-wide Binding Characteristics of Hlf
We were next interested in identifying the genomic regions
occupied by Hlf. For this, we generated a retroviral vector ex-
pressing a FLAG-tagged variant of Hlf and used this to infect
LinSca-1+c-Kit+ (LSK) cells. Although HSCs are included in
the LSK fraction, the majority of cells in this population (>95%)
represent multipotent progenitors (Bryder et al., 2006). There-
fore, most observed binding represents Hlf activity in multipotent
progenitors. Following 5 days of expansion, the infected cellsCell Reports 21, 2251–2263, November 21, 2017 2255
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Figure 4. Acute Hlf Depletion and Modulation of Hlf into a Transcriptional Repressor Lead to Enhanced Lymphopoiesis
Hlf-inducible GMLPs (CD45.1+) were transplanted into sublethally irradiated WT recipients (CD45.2+) on DOX food. After 14 days, one group of mice was shifted
to normal food and kept for another 8 days prior to analysis (‘‘Hlf depleted’’), while control mice were treated with DOX throughout the experiment (‘‘Hlf induced,’’
n = 7 and 6 mice, respectively, from one experiment).
(A) Data show the percentage of the indicated donor-derived cell types out of all CD45+ cells.
(B and C) The impact of Hlf target gene silencing on differentiation was studied by culturing control or M33-Hlf retrovirus infected WT GMLPs in B/NK and T cell
permissive conditions (n = 6 replicates per group from two experiments). Shown is the lineage output relative to controls of indicated subsets in OP9 cultures (B)
and OP9-DL1 cultures (C), respectively.
Error bars denote SEM.were next used for chromatin immunoprecipitation sequencing
(ChIP-seq) analysis using anti-FLAG or control antibodies. This
revealed Hlf peaks scattered around different genomic regions;
7.4% of the sites were located at promoters, 1.8% in UTR
regions, 45% at intragenic sites, and 45.8% in intergenic regions
(Figure S6A). Investigations into a putative underlying Hlf-binding
motif of the peaks revealed a predicted motif closely resembling
that reported for human HLF (Inaba et al., 1994) (Figure S6B).
Overrepresented gene ontology categories and mouse pheno-
types on the basis of the predicted Hlf-binding peaks associated
with blood cell development or immune system processes,
further supporting the notion of Hlf as a regulator of blood cell
formation (Figure S6C).
To investigate whether the intergenic peaks might overlap
with known enhancer regions, we intersected them with
enhancer regions recently identified in a variety of hematopoi-
etic cell types on the basis of H3K27Ac occupancy (Lara-
Astiaso et al., 2014) (Figure 5A). The elements bound by Hlf
associated with a random distribution of H3K27Ac in mature
B and T cells. In contrast, in long-term HSCs (LT-HSCs),
short-term HSCs (ST-HSCs), multipotent progenitor (MPP),
common myeloid progenitor (CMP), GMP, mature granulo-
cytes, and CLPs, Hlf peaks correlated with highly acetylated
H3K27Ac positioned on either side of the Hlf peak summit, sug-
gesting that Hlf may affect hematopoietic development by
regulating transcription also via enhancer elements (Figure 5A).
Further supporting this was the observation that identified
binding motifs of several other well-known hematopoietic
TFs, including c/EBP-like, Ets, Runx1, and AP1, co-associated
with the identified Hlf peak areas (Figure S6D).2256 Cell Reports 21, 2251–2263, November 21, 2017We thereafter compared the identified Hlf-bound regions with
those of other hematopoietic TFs. This revealed a strong corre-
lation between Hlf binding and c/EBP binding (Figure 5B), which
has been proposed previously (Hunger et al., 1992), and
suggested that Hlf might share c/EBP-binding sites during
hematopoietic development. To functionally test a redundancy
among these factors, we investigated if aberrant Hlf expression
may lead to transdifferentiation of B cells into macrophages, as
has previously been reported for C/EBP factors (Xie et al.,
2004). However, although Cebpb efficiently transdifferentiated
B cells into macrophages, Hlf was unable to do so (Figure 5C),
demonstrating that although the underlying binding motif of
Cebp and Hlf is similar, the functions of these factors are distinct.
Hlf Confers a Myeloid Fate on GMLPs that Is
Accompanied by a Deregulation of Lymphoid and
Myeloid Gene Expression Programs
Although our data suggested that Hlf acts as a strong lineage
fate determinant in multipotent progenitors, it remained a possi-
bility that one subset of GMLPs responded to Hlf by allowing
enhanced myelopoiesis, while an alternative lymphoid-compe-
tent subset was selectively depleted. To investigate this, using
fluorescence-activated cell sorting (FACS), we sorted individual
Hlf-inducible GMLPs onto OP9 stromal cells under B and NK
cell-promoting conditions and analyzed their progeny 14 days
later. Forced Hlf induction significantly increased the cloning
frequency (the ability of single-seeded GMLPs to promote
growth of detectable progeny) by 50% (36.4% in the absence
and 54.5% in the presence of DOX) (Figure S7A). WT GMLPs
produced a variety of lineage outputs, in which lymphoid
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Figure 5. The Genome-wide Binding Characteristics of Hlf
WT LSK cells were transduced with either a control retroviral vector or a vector encoding an N-terminal FLAG-tagged variant of Hlf/Hlf and were subjected to
ChIP-seq analysis.
(A) The Hlf peaks were ranked in a decreasing peak height order, and H3K27Ac signal intensity (Lara-Astiaso et al., 2014) was plotted around the summit of the Hlf
peaks and is shown as heatmaps. The histograms at the top of each heatmap depict the average signal intensity around the Hlf peaks for each cell type.
(B) Correlation analysis of the putative Hlf targets with those of other hematopoiesis associated TFs.
(C) BM resident B cells were subjected to transdifferentiation experiments by transduction with retroviral vectors encoding Cebpb or Hlf and cultured for 4 days on
OP9 stromal cells prior to FACS analysis (representative FACS plots from two independent experiments).
ChIP, chromatin immunoprecipitation. See also Figure S6.potential was dominant (Figure 6A). In stark contrast, forced Hlf
expression caused most cells (96.5%) to produce only myeloid
progeny (Figure 6A). These data strongly suggested that Hlf
acts to divert lineage fate of multipotent GMLPs, rather than
exercising differential effects on already committed progenitors.
To investigate the genome-wide transcriptional consequences
underlying this, we next conducted RNA sequencing (RNA-
seq). We here used both viral-mediated overexpression inWT GMLPs and GMLPs from our inducible transgenic mouse
strain (Figure S7B). We chose to use these complementary ap-
proaches to try to overcome limitations associated with each
individual approach. By highly stringent analysis criteria, this
combinatory approach revealed 43 and 41 up- and downregu-
lated genes as a consequence of Hlf expression, respectively
(Figure 6B; Table S2). In general, the most differentially ex-
pressed genes were the same with the two approachesCell Reports 21, 2251–2263, November 21, 2017 2257
A B
C D
Figure 6. Hlf Instructs GMLPs to Adopt aMyeloid Fate by Upregulation of aMyeloid-Associated Transcriptional Program and a Concomitant
Downregulation of Lymphoid-Affiliated Genes
(A) Single Hlf-inducible GMLPs were maintained on OP9 stromal cells for 14 days. The lineage potential of each seeded GMLP was determined using FACS, by
scoring each well for the presence of B cells, NK cells, and myeloid cells. Shown is the distribution of the different colony types among the positive wells of the
control and DOX treated groups.
(B) Venn diagrams depicting the number of shared up- and downregulated genes following Hlf induction using the two complementary approaches (compared
with controls).
(C) Up- and downregulated genes, their fold changes compared with controls using both experimental strategies, and whether they were identified also using
ChIP-seq. See also Table S2.
(D) GSEA in which the commonly up- and downregulated genes were used as gene sets and correlated against the whole transcriptomes of pGMs and CLPs.
Error bars denote SEM. GSEA, gene set enrichment analysis. See also Figure S7.(Figure 6C; Table S2). In addition, we found evidence for Hlf bind-
ing to 18 of the 43 upregulated genes, whereas only 4 of 41
downregulated genes presented as candidate Hlf targets (Fig-
ure 6C), perhaps suggesting that Hlf acts primarily to activate
gene expression.
Next, we asked whether the up- and downregulated genes are
part of larger transcriptional programs involved in early lympho-2258 Cell Reports 21, 2251–2263, November 21, 2017and myelopoiesis. Here, we used the up- and downregulated
genes as gene sets for gene set enrichment analysis (GSEA)
(Subramanian et al., 2005) and correlated the whole transcrip-
tome of myeloid progenitors and CLPs against these genes
(Figure 6D). Despite the very short induction period, this revealed
striking associations of the upregulated genes with myeloid
progenitors and downregulated genes to CLPs (Figure 6D),
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Figure 7. Identification of Nfic as a Direct Hlf Target with Pronounced Functional Effects on Hematopoietic Differentiation
(A) UCSC Genome Browser track depicting the genomic context of Nfic with regard to accessible chromatin and histone modifications of indicated cell types
(assay for transposase-accessible chromatin using sequencing [ATAC-seq] and histonemodification data from Lara-Astiaso et al. (2014). The region occupied by
Hlf is highlighted.
(B) Luciferase reporter assay of the candidate Nfic enhancer using Hlf-inducible ESCs. Bars denote the mean firefly luciferase signal (±SEM) after normalization
against Renilla using the +6.5 kb, a minimal (Min) enhancer construct, or an empty reporter construct, with or without Hlf induction (triplicate cultures from one of
three representative experiments).
(C andD) Frequency of myeloid and B cells generated as a consequence of enforcedNfic expression. Shown are the ratios of percentageGFP+Gr1+myeloid cells
over GFP+CD19+ B cells for the indicated groups. Data are from one of three experiments with similar results (n = 6 cultures per group for all cultures except
day 14 Nfic, for which five cultures were analyzed). Enforced Nfic expression leads to a general loss of hematopoietic cells over time. Hlf-inducible GMLPs were
maintained in the absence (C) or presence (D) of DOX and were transduced with either a control (Migr1) or Nfic retroviral vector and were subsequently cultured
onOP9 stroma cells withmonitoring every 2 days for frequency of GFP+ cells (n = 1 replicate for days 0, 2, and 4 and n = 5 replicates for days 6, 8, 10, 12, and 14 for
the groups in both C and D).
Error bars denote SEM. See also Figure S7.emphasizing Hlf downregulation as a critical requirement for
early lymphoid development.
Identification of the TF Nfic as a Direct Target Gene
of Hlf
As a last part of our work, we explored whether we could identify
any direct candidate target gene(s) of Hlf that might further detail
its mechanism of action. For this, we generated retroviruses for
15 gene candidates selected on the basis of effect on transcrip-
tion and chromatin binding (Figure 6C). Transduced cells were
next assayed using the OP9 co-culture system. In preliminary
analyses, the TF Nfic presented with both relative reductions in
B cell and increases in myeloid output (Figure S7C). Closer inter-
rogation of the chromatin environment around the Nfic-associ-
ated Hlf peak revealed a putative enhancer accessible in
non-lymphoid cells (Figure 7A), and reporter assays in Hlf-induc-
ible embryonic stem cells (ESCs) confirmed Hlf-dependent acti-
vation using both a larger domain covering the Hlf peak (+6.5 kb)
and from a smaller domain (Min) restricted to encode the candi-
date Hlf-binding motifs (Figure 7B). However, although enforcedNfic expression had a strong and rapid negative effect on B cell
output (Figure 7C), transgenic Nfic expression eventually also led
to a reduction in myeloid cell output over time (Figure 7D), a
feature not observed upon enforced Hlf expression alone (Fig-
ure 6A). Interestingly, when enforcing Hlf expression in the
setting of Nfic overexpression, Hlf was able to counteract at least
some of this reduction in cell output (Figure 7E), suggesting that
the induction of Nfic alone cannot explain all the phenotypes
observed upon persistent Hlf expression.
DISCUSSION
According to the prevailing view of hematopoiesis, appropriate
blood cell formation is maintained in a hierarchical fashion
and involves a range of progenitors with alternative differentia-
tion and proliferation potentials. HSCs reside at the top of this
hierarchy and have for decades been acknowledged as the pri-
mary cell type necessary for lifelong production of mature blood
cells. Therefore, much focus has historically been aimed at isola-
tion of near pure populations of HSCs. With this has come theCell Reports 21, 2251–2263, November 21, 2017 2259
realization that the HSC pool might not be as homogeneous as
initially assumed. Rather, the pool of HSCs might be composed
of clones with alternative blood-forming potentials in terms of
both lineage potential and the magnitude of the mature cells
they give rise to (Goodell et al., 2015). Such ‘‘lineage-biased’’
HSC clones have been sub-classified by the retrospective
functional readout of single-cell transplanted mice and/or by
differential marker expression prior to functional assessment.
However, caveats of such work include the difficulty in distin-
guishing HSCs with declining differentiation and/or self-renewal
potential from HSCs that are truly biased toward a given lineage.
It is therefore conceivable that assessments of mechanisms
governing multipotency are more easily approached by the
study of cells that reside more proximal to the decision points
to be studied, including the GMLPs, which was the main cell
type studied here.
Our gene expression profiling revealed Hlf to be highly ex-
pressed in multipotent GMLPs. A failure to downregulate Hlf at
this developmental stage instructed GMLPs to adopt a myeloid
fate and was incompatible with B, T, and NK cell development.
When artificially turning Hlf into a transcriptional repressor by
its fusion to the polycomb member M33, we observed a
reciprocal phenotype, despite the otherwise highly lymphoid-
permissive conditions that associates with the OP9 and OP9-
DL1 differentiation systems. The failure to downregulate Hlf in
GMLPs coincided with repression of lymphoid-affiliated genes
and the concomitant induction of myeloid-associated genes,
with many of the latter identified as candidate Hlf targets also
by ChIP-seq.
An unexpected but to us highly interesting finding, given the
involvement of Hlf in E2A-HLF driven acute B cell leukemia,
was the prominent accumulation of a c-kit+CD19+ population
in the BM of Hlf-induced mice. Our approaches to characterize
these cells collectively suggested that they represent committed
B cell progenitors that are blocked in differentiation at a fraction
B-C stage, which was further supported by a rapid gain of c-Kit
expression of these cells upon Hlf induction. These cells also
accumulated in the BM of WT mice transplanted with Hlf-induc-
ible GMLPs, which coincided with a vastly decreased B cell
reconstitution in the periphery. Given the genomic context of
the E2A-HLF fusion oncogene, one outcome due to the more
extended expression pattern of E2A should be aberrant expres-
sion of HLF in cell types normally devoid of HLF. However, as we
have failed to observe leukemia upon Hlf induction, even
following extensive time periods, additional mechanisms other
than aberrant activation of Hlf target genes seem crucial for
E2A-HLF-mediated transformation. At the same time, our
studies appear in line with the observed phenotypes of murine
transgenic models of the E2A-HLF fusion that manifest with
myelo- rather than lymphoproliferation (Duque-Afonso et al.,
2015).
By searching for candidate target genes of Hlf that could help
explain the actions of Hlf on lineage commitment, we identified
prominent Hlf binding to an intronic enhancer of Nfic and robust
increases in Nfic mRNA expression upon Hlf induction.
Although little is known about the role of Nfic in hematopoiesis,
the Nfi family member Nfix was recently identified as a critical
modulator of hematopoietic lineage choice by repressing B2260 Cell Reports 21, 2251–2263, November 21, 2017lymphoid formation while maintaining myeloid activity (O’Con-
nor et al., 2015), suggesting redundancy among Nfi family
members with respect to this activity. On the other hand, Nfic
does not appear to explain all effects of Hlf, underscored not
the least by a general loss of cells upon enforced Nfic expres-
sion. Although outside the scope of the current work, perhaps
gene dosage and/or expression of alternative isoforms might
underlie the differences observed between Nfic induced by
Hlf and the retroviral approach we used, which does not
exclude the likelihood that other target genes collaborate with
Nfic to mediate a combined effect. When interrogating our Hlf
ChIP-seq data (see Experimental Procedures, Data and Soft-
ware Availability), we find Hlf binding to a recently identified
distal c-Kit enhancer (chr5: 75,729,914–75,732,243) (Aranda-
Orgilles et al., 2016). This might be relevant for our work, given
the upregulation of c-Kit we see in the B cell lineage, the
anti-apoptotic effect of c-kit signaling, and its downregulation
in both B and T cell development (Godfrey et al., 1992;
Rico-Vargas et al., 1994). Another potential candidate is the
TF Meis1, whose promoter is occupied by Hlf (chr11:
18,741,886–19,157,511). In previous work from Kumar and col-
leagues (Roychoudhury et al., 2015), Meis1 was suggested to
regulate Hlf expression, with Meis1 loss leading to pronounced
apoptosis. Our observations extend these findings to include
Hlf regulation of Meis1, indicative of a feedback loop between
these factors.
As it is becoming increasingly apparent that multipotent
progenitor cells other than HSCs are critical for steady-state
hematopoiesis even over extended time periods (Busch et al.,
2015; Sun et al., 2014), we believe that the ability of Hlf to
strongly direct differentiation of an otherwise multipotent pro-
genitor toward specific lineages is most relevant. A deeper
understanding of the regulatory circuits governed by Hlf will
not only be important to understand physiological blood cell
formation but will likely also lead to an increased understanding
of the leukemic processes that are characterized by involvement
of Hlf.EXPERIMENTAL PROCEDURES
Further details and an outline of resources used in this work can be found in
Supplemental Experimental Procedures.
Generation of Viral Vectors
Viral constructs were generated using PCR-mediated Gibson Assembly and
T4 DNA ligase cloning (New England Biolabs). Lentiviruses were produced
by transient transfection of 293T producer cells and retroviruses by transient
transfection into Plat-erythroid packaging cells.
Generation of Transgenic Mice and In Vivo Hlf Transgenic Strategy
DOX-inducible Hlf transgenic mice were generated by cloning the coding
sequence and the 50 and 30 UTR of the murine Hlf gene into the pBS31 target-
ing vector (Beard et al., 2006). Next, the pBS31-Hlf construct was used to
target KH2 ESCs by Flpase-mediated recombination (Beard et al., 2006).
See Figure S3B for a schematic of the model. Following successful targeting,
engineered ESCs were used to generate transgenic mice, which were
backcrossed to CD45.1+ C57BL/6 mice and bred to homozygosity for the
modified loci. Transgenic Hlf expression in vivowas achieved by administering
DOX-containing chow ad libitum (2 g/kg; Bio-Serv). All animal experiments
were performed with consent from a local ethics committee.
Immunophenotypic Analysis and Cell Sorting
For isolation and analysis of HSCs, the indicated progenitor populations and
mature cells by FACS were performed as previously described (Inlay et al.,
2009; Pronk and Bryder, 2011; Pronk et al., 2007; Tung et al., 2004).
In Vitro Evaluation of NK, B, and T Cell Potential by OP9/OP9-DL1
Co-culture
To determine the differentiation potential of Hlf-inducible GMLPs, cells were
sorted directly into 48-well plates (bulk cultures) or 96-well plates (single-cell
cultures) pre-plated with OP9 or OP9-DL1 stromal cells. In some experiments,
WT GMLPs were instead first transduced viral vectors before stromal cell
co-culture. B/NK cell permissive cultures were maintained on OP9 stroma
cells in medium containing 20 ng/mL interleukin-15 (IL-15), 40 ng/mL IL-2,
10 ng/mL stem cell factor (SCF), 10 ng/mL fms-like tyrosine kinase 3 ligand
(Flt3L), and 10 ng/mL IL-7, while T cells were generated on OP9-DL1 stroma
supplemented with 10 ng/mL Flt3L and 10 ng/mL IL-7. Hlf-inducible cultures
were maintained in the presence or absence of 1 mg/mL DOX (Sigma-Aldrich).
Cultureswere evaluated at the indicated time points by cell counting and FACS
analysis.
Evaluation of Apoptosis
To investigate whether Hlf expression resulted in increased levels of apoptosis
in B and T lymphoid progenitors, thymic CD4+CD8+ and BM-derived fraction
B-C cells were FACS-sorted from Hlf-inducible mice and cultured on
OP9-DL1 and OP9, respectively, with or without DOX (1 mg/mL) for 48 hr.
Next, fraction B-C cultures were stained with a c-Kit antibody (2B8;
eBioscience), and both culture types were thereafter incubated with
annexin V conjugated to Cy5 and propidium iodide for 15 min before immedi-
ate FACS analysis.
Reconstitution Experiments
Eight thousand five hundred to 15,000 Hlf-inducible GMLPs (CD45.1+) were
transplanted into sublethally irradiated (500 rad) WT CD45.2+ C57BL/6 recip-
ient mice preconditioned for 5 days prior to transplantation by allowing mice to
eat DOX-containing food. The mice were kept on a DOX pellet diet for 21 days
(when investigating the effects of prolonged Hlf expression) or 22 days and
14 days followed by 8 days with a normal diet (when investigating the effect
of DOX withdrawal on the established phenotypes) post-transplantation;
BM, spleen, thymus, and PB of the recipient mice were analyzed for donor
reconstitution.
Affymetrix Gene Expression Analysis and qRT-PCR
Microarray data were analyzed using dChip (Li and Hung Wong, 2001). For
qRT-PCR experiments, the indicated populations were FACS-sorted directly
into RLT lysis buffer and purified using the RNeasy Micro mRNA purification
kit (QIAGEN), followed by first-strand cDNA synthesis as previously described
(Norddahl et al., 2011). In some cases, the cDNA was amplified using KAPA
HiFi Hotstart Readymix (Kapa Biosystems). qRT-PCRs were run with SYBR
GreenER (Invitrogen) or EvaGreen (Bio-Rad).
ChIP-Seq Experiments
WT LSK cells were infected with a pMX-GFP control or a pMX-3xFLAG-Hlf/
Hlf-IRES-GFP virus and grown for 5 days in basal OP9 medium supplemented
with 50 ng/mL SCF, 10 ng/mL IL-7, 10 ng/mL Flt3L, and 5 ng/mL IL-3 (all from
Peprotech). Next, 2 3 107 cells were cross-linked in 1% formaldehyde, and
nuclei were prepared and snap-frozen in a dry ice/isopropanol bath. The
frozen nuclei were lysed, and chromatin was sonicated in a Bioruptor (Diage-
node) before immunoprecipitating with a FLAG-tag antibody (F3165; Sigma-
Aldrich). Next, cross-links were reversed, and DNA was purified using
QIAGEN PCR clean-up columns. Sequencing libraries were prepared using
the Illumina TruSeq ChIP sample preparation kit (IP-202-1012; Illumina) and
sequenced on an Illumina HiSeq 2500. Further details along with data-pro-
cessing regimens can be found in Supplemental Experimental Procedures.
RNA-Seq
WT GMLPs were transduced with pHAGE2-Hlf/Hlf-IRES-ZsGreen or a
pHAGE2 control virus, and Hlf-inducible GMLPs maintained in the presenceor absence of DOX were cultured on OP9 stroma in B/NK cell conditions
for 4 days. Next, ZsGreen+/CD45+ cells were FACS-sorted. Following RNA
purification, libraries were prepared by the SMARTer Ultra Low Input RNA
Kit for Sequencing (Clontech), and RNA-seq analysis was performed using
an Illumina HiSeq 2500 platform by the Genome Technology Access Center
(GTAC; Washington University School of Medicine). Data-processing details
can be found in Supplemental Experimental Procedures.
B Cell Transdifferentiation Experiments
B cell-to-macrophage transdifferentiation experiments were performed in
essence as previously described (Xie et al., 2004). In brief, 100,000 BM-resi-
dent B220+CD19+ B cells were isolated by FACS and transduced on retronec-
tin-coated plates with a MigR1 control virus, MigR1-Hlf, and a MigR1-Cebpb
virus and cultured on OP9 stroma for 4 days in basal OP9 medium supple-
mented with SCF, M-CSF, IL-3, IL-7, and Flt3L (all at 10 ng/mL) prior to
FACS analysis.
VDJ Rearrangement PCR
The PCR reactions were run using 10,000 cells of each indicated population
exactly as previously described (Schlissel et al., 1991).
Luciferase Assays
A 1 kb fragment containing the Hlf-bound region of the Nfic gene or a more
specific 204 bp region containing three candidate HLF-binding sites was in-
serted into the pGL2 vector upstream of a SV40 promoter sequence and firefly
luciferase reporter. The resulting vectors, or an empty pGL2 vector, were used
to co-transfect Hlf-inducible ESCs maintained with or without DOX using
Lipofectamine LTX reagent (Invitrogen) together with a Renilla luciferase re-
porter gene plasmid. Luciferase reporter signals were determined 24 hr
post-transfection using the Dual-Luciferase Reporter Assay System kit
(Promega).
Statistics
Data analysis was performed using Microsoft Excel and GraphPad Prism
(GraphPad Software). All FACS data were analyzed with FlowJo (Tree Star).
The heatmap in Figure 1B was prepared using GEN-E (http://www.
broadinstitute.org/cancer/software/GENE-E/index.html). Venn diagrams
were generated using Venny (Oliveros, 2007–2015). Significance values, with
the exception of Figure 4A (splenic T cell reconstitution), for which a Mann-
Whitney test was used, were calculated using Student’s two-tailed t test,
and a p value of <0.05 was considered to indicate statistical significance.
DATA AND SOFTWARE AVAILABILITY
The accession numbers for the microarray data reported in this paper are
GEO: GSE44923 and GEO: GSE27686 (HSCs); GEO: GSE8407 (Pre Meg/
erythroid, Pre CFU-erythroid, CFU-erythroid, MkP, pGM and CLP); GEO:
GSE18734 (GMLP); and GEO: GSE14833 (GMP). The accession number for
the generated ChIP-seq data reported in this paper is GEO: GSE69817. Our
ChIP data can also be visualized using a customUniversity of California, Santa
Cruz (UCSC), Genome Browser session (http://genome-euro.ucsc.edu/
cgi-bin/hgTracks?hgS_doOtherUser=submit&hgS_otherUserName=promufa&
hgS_otherUserSessionName=Lund_160719) together with previously estab-
lished ChIP data (Lara-Astiaso et al., 2014). The accession number for the
RNA-seq data reported in this paper is GEO: GSE69858.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and two tables and can be found with this article online at
https://doi.org/10.1016/j.celrep.2017.10.112.
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